Amplicon details |
||
Amplicon: |
75 bp | |
1 aaagcaagtg gattgatgtg atatctccac tgacgtaagg gatgacgcac 51 aatcccacta tccttcgcaa gaccc |
||
| Record ID | Database | Record description | Record length | Taxon | Method | Amplicon size | Match details |
|---|---|---|---|---|---|---|---|
| LY656145.1 | emblrelpat | KR 1020190052745-A/2: Manufacturing... | 4193 bp | synthetic construct | QL-ELE-00-017 | 75 bp | View |
| LY656146.1 | emblrelpat | KR 1020190052745-A/3: Manufacturing... | 4205 bp | synthetic construct | QL-ELE-00-017 | 75 bp | View |
| LY660357.1 | emblrelpat | KR 1020190016466-A/21: Mutant anti-... | 16454 bp | synthetic construct | QL-ELE-00-017 | 75 bp | View |
| LY667603.1 | emblrelpat | KR 1020190003994-A/5: NUCLEIC ACID ... | 7059 bp | synthetic construct | QL-ELE-00-017 | 75 bp | View |
| LY668962.1 | emblrelpat | KR 1020190008933-A/9: PLANT REGULAT... | 631 bp | synthetic construct | QL-ELE-00-017 | 75 bp | View |
| LY670910.1 | emblrelpat | KR 1020190026725-A/3: A method of h... | 835 bp | synthetic construct | QL-ELE-00-017 | 75 bp | View |
| LY709459.1 | emblrelpat | KR 1020190050862-A/1: METHOD OF PRE... | 3067 bp | synthetic construct | QL-ELE-00-017 | 75 bp | View |
| LY716705.1 | emblrelpat | KR 1020190102964-A/5: Transgenic to... | 623 bp | synthetic construct | QL-ELE-00-017 | 75 bp | View |
| LY798569.1 | emblrelpat | KR 1020200004185-A/1: Gene delivery... | 16236 bp | synthetic construct | QL-ELE-00-017 | 75 bp | View |
| LY798570.1 | emblrelpat | KR 1020200004185-A/2: Gene delivery... | 14014 bp | synthetic construct | QL-ELE-00-017 | 75 bp | View |
| LY798571.1 | emblrelpat | KR 1020200004185-A/3: Gene delivery... | 15496 bp | synthetic construct | QL-ELE-00-017 | 75 bp | View |
| LY802596.1 | emblrelpat | KR 1020200011845-A/1: Virus-induced... | 16236 bp | synthetic construct | QL-ELE-00-017 | 75 bp | View |
| LY802597.1 | emblrelpat | KR 1020200011845-A/2: Virus-induced... | 13906 bp | synthetic construct | QL-ELE-00-017 | 75 bp | View |
| LY802598.1 | emblrelpat | KR 1020200011845-A/3: Virus-induced... | 14142 bp | synthetic construct | QL-ELE-00-017 | 75 bp | View |
| LY803191.1 | emblrelpat | KR 1020200022970-A/5: Production me... | 623 bp | synthetic construct | QL-ELE-00-017 | 75 bp | View |
| LY988634.1 | emblrelpat | KR 1020200039775-A/29: TARGET SEQUE... | 820 bp | synthetic construct | QL-ELE-00-017 | 75 bp | View |
| LY998755.1 | emblrelpat | KR 1020200056434-A/153: TISSUE-PREF... | 11210 bp | synthetic construct | QL-ELE-00-017 | 75 bp | View |
| LY998756.1 | emblrelpat | KR 1020200056434-A/154: TISSUE-PREF... | 15172 bp | synthetic construct | QL-ELE-00-017 | 75 bp | View |
| LY998757.1 | emblrelpat | KR 1020200056434-A/155: TISSUE-PREF... | 15352 bp | synthetic construct | QL-ELE-00-017 | 75 bp | View |
| LY998758.1 | emblrelpat | KR 1020200056434-A/156: TISSUE-PREF... | 15433 bp | synthetic construct | QL-ELE-00-017 | 75 bp | View |
Related publications:
Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101.
Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.